Welcome to our dedicated page for Molina Hlthcare SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for Molina Healthcare, Inc. (NYSE: MOH), a FORTUNE 500 company that provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. These regulatory documents offer detailed insight into how Molina reports its operations, capital structure, and material events.
Among the key filings are Form 8-K current reports, where Molina discloses material developments. Recent 8-Ks describe the private offering of 6.500% Senior Notes due 2031, including interest terms, maturity, ranking, redemption features, and the related indenture. Other 8-Ks outline a new revolving credit facility, amendments to the company’s credit agreement, and a delayed draw term loan used to partially fund a stock repurchase program.
Additional 8-K filings furnish earnings releases for specific quarters, summarizing premium revenue, total revenue, net income, medical care costs, medical care ratios, and segment performance for Medicaid, Medicare, and marketplace operations. These reports also include reconciliations of non-GAAP measures such as adjusted net income, EBITDA, and Adjusted EBITDA, along with explanations of how these metrics are calculated and their limitations.
Investors can also review filings that discuss Medicaid and CHIP contract developments, such as the Notice of Agency Decision indicating an intent to award Molina Healthcare of Florida a Statewide Medicaid Managed Care and Children’s Health Insurance Program contract for the Children’s Medical Services Program. These documents help explain how new or renewed contracts may affect membership and premium revenue.
On Stock Titan, Molina Healthcare’s filings are updated as they are released on EDGAR, and AI-powered summaries highlight the main terms, financial impacts, and segment implications of each document. This allows users to quickly understand complex credit agreements, debt offerings, and earnings disclosures without reading every page of the underlying filing.
Schapiro Richard M reported acquisition or exercise transactions in this Form 4 filing.
MOLINA HEALTHCARE, INC. director Richard M. Schapiro received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The award represents one quarterly installment of a $220,000 annual equity grant, with this quarter’s $55,000 portion based on the $135.82 closing share price. Following the grant, Schapiro directly holds 12,074 common shares.
Molina Healthcare director Barbara L. Brasier received a grant of 405 shares of common stock as compensation for board service. The award was made on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The quarterly grant was valued at $55,000, based on the $135.82 closing price of Molina Healthcare stock that day. Brasier now directly holds 5,581 shares following this non‑market, compensation-related acquisition.
ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Ronna Romney received an equity grant through a revocable trust. On April 1, 2026, the Ronna Romney Revocable Trust was awarded 405 shares of Molina Healthcare common stock at a reference price of $135.82 per share under the company’s 2025 Equity Incentive Plan. This quarterly grant represents one quarter of an annual director equity award valued at $220,000, structured as $55,000 in stock each quarter based on the closing market price that day. Following this award, the trust holds a total of 17,632 shares, reflecting routine, compensation-related ownership rather than an open-market purchase or sale.
Molina Healthcare Inc: The Vanguard Group filed an amended Schedule 13G/A reporting 0 shares and 0% beneficial ownership of common stock. The filing states an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries/divisions to report separately. The amendment is signed by Ashley Grim on 03/27/2026.
Molina Healthcare, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on five key items: electing ten directors for one-year terms, approving 2025 executive pay on an advisory basis, ratifying Ernst & Young LLP as 2026 auditor, expanding the 2025 Equity Incentive Plan share pool, and amending the Certificate of Incorporation to allow stockholders to call special meetings.
The Board highlights a government-focused growth strategy, serving about 5.5 million members across 21 states as of December 31, 2025, supported by multiple new Medicaid and Medicare contracts and the $350 million acquisition of ConnectiCare. Governance features include an independent chair, fully independent committees, director stock ownership guidelines, 12-year term limits for new independent directors, and a robust Board and committee evaluation process.
Molina Healthcare director Ronna Romney, through the Ronna Romney Revocable Trust, reported an open-market sale of 506 shares of Common Stock on March 12, 2026. The shares were sold at a volume-weighted average price of $146.92 per share, with individual trade prices ranging from $146.80 to $147.10.
Following this transaction, the trust continues to hold 17,227 Molina Healthcare shares indirectly attributed to Romney. The sale represents a relatively small portion of the trust’s overall reported holdings and appears as a routine portfolio adjustment rather than a large position change.
Molina Healthcare, Inc. is soliciting proxies for its 2026 Annual Meeting to be held virtually on May 6, 2026; stockholders of record as of March 9, 2026 may vote.
The proxy asks stockholders to: elect ten directors; approve an advisory say-on-pay vote for 2025 executive compensation; ratify Ernst & Young LLP as auditor for 2026; approve an amendment to the 2025 Equity Incentive Plan to increase shares available; and amend the Certificate of Incorporation to permit stockholders to call special meetings. The company reports serving approximately 5.5 million members as of December 31, 2025 and discloses notable recent contracts and the acquisition of ConnectiCare for $350 million effective February 1, 2025.
Filer: Fidelity Brokerage Services LLC filed a Form 144 reporting an intended sale of Common stock related to holdings on the NYSE.
The filing lists transaction identifiers including 506, 74220.08, and 51500000, and references 03/11/2026. The entries show prior stock awards dated 04/05/2023 (206 shares) and 01/02/2014 (300 shares).
Molina Healthcare President & CEO Joseph M. Zubretsky reported equity compensation transactions in company common stock. On March 1, 2026, 8,597 shares were disposed of at $154.05 per share to cover withholding taxes tied to the vesting of 20,623 shares of previously granted stock.
On the same date, he received a grant of 66,417 restricted shares at a reference price of $145.75, determined using the volume-weighted average price over the ten trading days before March 1, 2026, under the 2025 Equity Incentive Plan. These 66,417 shares are scheduled to vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029, with additional tranches of 13,075 shares vesting on March 1, 2027 and 7,497 shares on March 1, 2028.
After these transactions, he directly owned 99,015 shares and indirectly held 257,715 shares through the Joseph M. Zubretsky Revocable Trust, where he serves as sole trustee.